ScholarLens Back to search
2023•Unpublished venueOpen access

Supplementary Figure 2 from NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants

Nagalakshmi Nadiminty, Ramakumar Tummala, Chengfei Liu, Joy C. Yang, Wei Lou, Christopher P. Evans, Allen C. Gao

Open full text 0 citations

Abstract

PDF file - 118K, Expression levels of anti-apoptotic proteins in LNCaP cells expressing p52 compared to control cells.

Open-access reader

About this research paper

What this paper is about

PDF file - 118K, Expression levels of anti-apoptotic proteins in LNCaP cells expressing p52 compared to control cells.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

PDF file - 118K, Expression levels of anti-apoptotic proteins in LNCaP cells expressing p52 compared to control cells.

Key concepts: Enzalutamide, Androgen receptor, Prostate cancer, Cancer research, Medicine, Receptor, Cancer, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Supplementary Figure 2 from NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants — Research Paper | ScholarLens